ANZ Bank's annual shareholders' meeting was by no means as acrimonious as Westpac's last week but chair David Gonski adopted a conciliatory and contrite attitude.

New Zealand shares were slightly weaker when trading ended early as the stock market operator dealt with connectivity issues.

New Zealand shares fell as Z Energy’s warning of lower profits and smaller dividends cast a long shadow over the market.

New Zealand shares rose as the government’s efforts to stoke the economy with infrastructure spending continued to overshadow uncertainties around Brexit and the lingering China-US trade talks.

New Zealand shares edged higher after a late rally, with most port stocks stronger ahead of tomorrow’s release of the upper North Island supply chain study recommending Northport take over as the principal import port for Auckland.

NZ shares rose as A2 Milk recovered from yesterday's decline on the surprise departure of its chief executive, while blue-chip stocks Ryman Healthcare and F&P Healthcare also booked strong gains.

New Zealand shares fell, led by A2 Milk after the milk marketing company’s chief executive unexpectedly left the company, effective immediately.

A2 Milk Co chief executive and managing director Jayne Hrdlicka will step down from her role effective immediately and former head Geoffrey Babidge will take the helm while a search for a replacement is underway.

New Zealand shares rose as investors count down for China and the US to cut a trade deal before tariffs take effect in 10 days.

New Zealand shares rose as bank stocks rallied when the Reserve Bank's new capital adequacy rules weren’t as harsh as some investors feared.

New Zealand shares dipped ahead of major regulatory decisions on domestic banking and fuel markets tomorrow.

New Zealand shares joined a global sell-off as a revival in US trade protectionism added to pessimism among global investors. Local exporters were among the hardest hit as a stronger kiwi dollar combined with the souring sentiment.

New Zealand shares snapped five days of gains, led lower by Gentrack as investors fretted over how the utilities software developer will cope with ongoing turmoil in Britain’s electricity market.

The S&P/NZX 50 Index rose 4.9 percent in November as retirement village operators were boosted by potential merger and acquisition activity and A2 Milk mounted a comeback on strong earnings guidance.

The S&P/NZX 50 Index hit a record as investor sentiment was buoyed by a recovery in the latest business confidence survey and a better than expected earnings season, and a growing appetite among private equity buyers to pursue mergers and acquisitions.

NZ shares rose as Fisher & Paykel Healthcare gained, cracking $12 billion in market value after lifting first-half profit.